Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Carlyle to take control of Very Group from Barclay family - report

(Sharecast News) - US investment firm Carlyle is reportedly preparing to take control of online retailer Very Group in a deal that will end the Barclay family's long tenure at another major UK company. According to Sky News, Carlyle - the biggest lender to Very Group's immediate parent company - could assume ownership of the retailer as soon as October under the terms of its financing arrangements.

Sources told Sky on Friday that Carlyle was expected to hold further talks in the coming weeks with fellow creditors including IMI, the Abu Dhabi-based vehicle which assumed part of Very Group's debts in a complex deal related to ownership of the Telegraph newspaper titles.

Sources said Carlyle will probably end up holding a majority stake in Very Group once it exercises a 'step-in right' which effectively converts its debt into equity ownership.

Very Group borrowed a further £600m from Mayfair-based fund Arini this year as it sought to stave off a cash crunch and buy itself breathing space.

Sky said precise details of the company's capital and ownership structure will be thrashed out before the change of control rights are triggered at the beginning of October.

The Barclay family drew up plans to hire bankers to run an auction of Very Group earlier this year, but a process was never formally launched.

It was understood that Carlyle, which declined to comment to Sky, may hold onto the business for a further period before looking to offload it.

IMI is also likely to end up with an equity stake or a preferred position in the recapitalised company's debt structure, sources told Sky.

Very Group has around 4.5 million customers.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.